Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-017035

Director acquired 1,174 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2023-12-01 Other acquisition 10b5-1 +72 $1.69 $122 31,305 D
Jones James Director 2023-12-04 Other acquisition 10b5-1 +64 $1.72 $110 31,369 D
Jones James Director 2023-12-05 Other acquisition 10b5-1 +72 $1.69 $122 31,441 D
Jones James Director 2023-12-06 Other acquisition 10b5-1 +72 $1.70 $122 31,513 D
Jones James Director 2023-12-07 Other acquisition 10b5-1 +34 $1.65 $56 31,547 D
Jones James Director 2023-12-08 Other acquisition 10b5-1 +72 $1.83 $132 31,619 D
Jones James Director 2023-12-11 Other acquisition 10b5-1 +82 $1.85 $152 31,701 D
Jones James Director 2023-12-12 Other acquisition 10b5-1 +87 $1.77 $154 31,788 D
Jones James Director 2023-12-13 Other acquisition 10b5-1 +82 $1.80 $148 31,870 D
Jones James Director 2023-12-14 Other acquisition 10b5-1 +82 $1.86 $153 31,952 D
Jones James Director 2023-12-15 Other acquisition 10b5-1 +82 $1.89 $155 32,034 D
Jones James Director 2023-12-18 Other acquisition 10b5-1 +81 $1.80 $146 32,115 D
Jones James Director 2023-12-19 Other acquisition 10b5-1 +81 $1.73 $140 32,196 D
Jones James Director 2023-12-20 Other acquisition 10b5-1 +124 $1.76 $218 32,320 D
Jones James Director 2023-12-21 Other acquisition 10b5-1 +87 $1.70 $148 32,407 D
Loading xslF345X05/marketforms-63938.xml…